1 Introduction Continuous-flow left ventricular assist devices (LVADs) have become a standard treatment for advanced heart failure, with about 80% of implantations classified as destination therapy [1]. However, these devices induce shear stress on red blood cells (RBCs), which can lead to hemolysis [2]. Hemolysis refers to RBC damage, leading to the release of hemoglobin into plasma, which can occur either through pore formation in the RBC membrane or through complete rupture [2].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile